Novavax is a global biotechnology company with a proven vaccine technology. We’re focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health. With a strong scientific foundation, our technology includes both our recombinant protein-based nanoparticle and Matrix-M™ adjuvant.

Our goal is to exponentially increase the impact of our technology in areas of unmet need. We are focused on doing this through: